A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.
| Image |  |
|---|---|
| Description | scientific article published on 29 January 2012 |
| Author/s |
author: Marco Mura |
| Publication date | January 29, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |